TNF and rheumatoid arthritis: Several studies in both human RA and animal models have shown that therapeutic interventions with biological agents, such as tumor necrosis factor (TNF) or interleukin‐6 receptor (IL‐6R) blockers, lead to the resolution of synovitis as well as inhibition of joint damage progression.